Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intracanal medications for apical periodontitis in healthy adults and head-and-neck radiotherapy patients
RBR-6j98hjxPhase 2Recruiting
- Sponsor
- Instituto de Ciência e Tecnologia UNESP
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of calcium hydroxide, chlorhexidine and acetylcysteine in apical periodontitis (AP) and Primary endodontic infection (PEI) (7 arms), sponsored by Instituto de Ciência e Tecnologia UNESP. Primary endpoints: Total bacterial load in root canals, Bacterial profile by checkerboard analysis and 2 more. Started Mar 2022; status: recruiting.
02
Drugs
calcium hydroxidechlorhexidineacetylcysteine
03
Conditions
apical periodontitis (AP)Primary endodontic infection (PEI)
Beyond the preview
Go deeper on RBR-6j98hjx.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-6j98hjx.